Axonics® expands sacral neuromodulation intellectual property portfolio

Irvine, calif.--(business wire)--axonics, inc. (nasdaq: axnx), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today announced that in the last twelve months, the united states patent and trademark office has granted eight patents and allowed four patent applications related to the company's sacral neuromodulation technology. the patents and allowed applications are part of axonics' patent portfolio an
AXNX Ratings Summary
AXNX Quant Ranking